نتایج جستجو برای: familial chylomicronemia

تعداد نتایج: 56099  

2016
Atsushi Obata Shinji Kamei Seizo Okauchi Tomohiko Kimura Hidenori Hirukawa Akihito Tanabe Tomoe Kinoshita Kenji Kohara Fuminori Tatsumi Masashi Shimoda Shuhei Nakanishi Tomoatsu Mune Kohei Kaku Hideaki Kaneto

INTRODUCTION It is known that chylomicronemia is caused by several pathologies and is classified as primary and secondary chylomicronemia. Since hypertriglycemia is associated with an increased risk of cardiovascular disease and severe pancreatitis, it is very important to make a proper diagnosis of the cause of hypertriglycemia. CASE DESCRIPTION We herein present the case of a 40-year-old ma...

2010
Hanan AL Azkawi Ibrahim AlAlwan

There are no adequate data that evaluate the safety and effectiveness of lowering triglyceride levels in very young children. The authors report a family with two male siblings, 7 and 4 years old, affected by familial hyperchylomicronemia. The oldest was diagnosed at birth during evaluation of jaundice, and the youngest showed asymptomatic hypertriglyceridemia by 6 months of age. Due to high tr...

Journal: :Cureus 2023

Introduction: Severe hypertriglyceridemia (SHTG) is a rare condition associated with serious complications, such as acute pancreatitis (AP), and the best treatment still matter of discussion. The aim this study to outline demographics, management, outcomes (recurrence mortality) complications in patients SHTG. Material methods: A retrospective, observational, analytical was carried out by obtai...

Journal: :Journal of Lipid Research 2020

Journal: :The Tohoku Journal of Experimental Medicine 1991

Journal: :Journal of lipid research 1983
J D Brunzell N E Miller P Alaupovic R J St Hilaire C S Wang D L Sarson S R Bloom B Lewis

A mother and her son who have lipoprotein phenotype I are described. They differed from subjects with lipoprotein lipase deficiency in that lipoprotein lipase was present in adipose tissue respectively at 30- and 2-fold the levels seen in normal subjects, and from subjects with apoprotein C-II deficiency in that apoprotein C-II was present in their plasma. They appeared to have an inhibitor to ...

2017
Chao Liu Daniel Gaudet Yury I. Miller

Hypertriglyceridemia is an independent risk factor for cardiovascular disease. Apolipoprotein C-II (APOC2) is an obligatory cofactor for lipoprotein lipase (LPL), the major enzyme catalyzing plasma triglyceride hydrolysis. We have created an apoc2 knockout zebrafish model, which mimics the familial chylomicronemia syndrome (FCS) in human patients with a defect in the APOC2 or LPL gene. In this ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید